
Glimtoss PZ 1mg/500mg/15mg Tablet
Marketer
Astonea Labs Private Limited
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimtoss PZ 1mg/500mg/15mg Tablet
Combiflex DM 1mg/500mg/15mg tablets offer a multi-component approach to managing elevated blood glucose. This medication, used in conjunction with a healthy diet and regular exercise, improves glycemic control in adult patients with type 2 diabetes. It enhances insulin effectiveness, leading to reduced blood sugar. Always adhere to your physician's prescribed dosage and regimen for Combiflex DM 1mg/500mg/15mg tablets. Taking it with food minimizes potential stomach discomfort. If a dose is missed, take it immediately; however, if the next dose is imminent, omit the missed one and resume your regular schedule. Never double the dose. An overdose can result in dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol consumption, or skipped meals increases the risk of hypoglycemia. Regular blood glucose monitoring is crucial. Common adverse reactions may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should seek medical counsel before use. Kidney function tests will be performed before treatment initiation. Limit alcohol consumption during treatment to mitigate potential side effects.
Uses of Glimtoss PZ 1mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Glimtoss PZ 1mg/500mg/15mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid crushing, chewing, or fracturing it. Consume Glimtoss PZ 1mg/500mg/15mg tablets with food.
Common Side effects of Glimtoss PZ 1mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimtoss PZ 1mg/500mg/15mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Consume Glimtoss PZ 1mg/500mg/15mg tablets with food.
How Glimtoss PZ 1mg/500mg/15mg Tablet works:
Glimtoss PZ 1mg/500mg/15mg tablets contain glimepiride, metformin, and pioglitazone, three antidiabetic agents with distinct modes of action. This triple combination improves blood sugar management when single or dual-agent therapies prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, decreases hepatic glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimtoss PZ 1mg/500mg/15mg Tablet with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Glimtoss PZ 1mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimtoss PZ 1mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glimtoss PZ 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. Glimtoss PZ 1mg/500mg/15mg tablets are contraindicated in those with severe kidney disease. Regular kidney function monitoring is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Glimtoss PZ 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. The use of Glimtoss PZ 1mg/500mg/15mg tablets is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimtoss PZ 1mg/500mg/15mg Tablet :
Should you forget a Glimtoss PZ 1mg/500mg/15mg Tablet dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimtoss PZ 1mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Medication for diabetes |
